Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: A randomized phase II trial

International Breast Cancer Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Neoadjuvant degarelix versus triptorelin in premenopausal patients who receive letrozole for locally advanced endocrine-responsive breast cancer: A randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences